Functional assays confirmed that AML samples expressing high levels of BMPR1A contain 15-fold more immature cells able to generate LTC-IC (P = 0.0426) but as many more mature progenitors identified as CFCs as BMPR1Alow AML samples (Fig. 2g). The gene discussed is BMPR1A; the disease is acute myeloid leukemia.